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We used two-dimensional difference gel electrophore-
sis to determine early changes in the stress-response
pathways that precede focal adhesion disorganization
linked to the onset of apoptosis of renal epithelial cells.
Treatment of LLC-PK1 cells with the model nephrotoxi-
cant 1,2-(dichlorovinyl)-L-cysteine (DCVC) resulted in a
>1.5-fold up- and down-regulation of 14 and 9 proteins,
respectively, preceding the onset of apoptosis. Proteins
included those involved in metabolism, i.e. aconitase
and pyruvate dehydrogenase, and those related to stress
responses and cytoskeletal reorganization, i.e. cofilin,
Hsp27, and -b-crystallin. The most prominent changes
were found for Hsp27, which was related to a pI shift in
association with an altered phosphorylation status of
serine residue 82. Although both p38 and JNK were ac-
tivated by DCVC, only inhibition of p38 with SB203580
reduced Hsp27 phosphorylation, which was associated
with accelerated reorganization of focal adhesions, cell
detachment, and apoptosis. In contrast, inhibition of
JNK with SP600125 maintained cell adhesion as well as
protection against apoptosis. Active JNK co-localized at
focal adhesions after DCVC treatment in a FAK-depend-
ent manner. Inhibition of active JNK localization at fo-
cal adhesions did not prevent DCVC-induced phospho-
rylation of Hsp27. Overexpression of a phosphorylation-
defective mutant Hsp27 acted as a dominant negative
and accelerated the DCVC-induced changes in the focal
adhesions as well as the onset of apoptosis. Our data fit
a model whereby early p38 activation results in a rapid
phosphorylation of Hsp27, a requirement for proper
maintenance of cell adhesion, thus suppressing renal
epithelial cell apoptosis.
Acute renal failure, caused by either ischemia/reperfusion
injury or exposure to nephrotoxic xenobiotics, is still an impor-
tant clinical problem. Renal proximal tubular epithelial cells
(PTC)1 are the primary target, and injury to these cells results
in either the onset of necrosis or apoptosis, depending on the
severity of the injury. There is increasing evidence that suble-
thal PTC injury results in changes in cell adhesion at the level
of cellular to extracellular matrix interactions at focal adhe-
sions (1). These interactions are under the tight control of
dynamic changes of the F-actin cytoskeleton. Likewise,
changes in the cellular interactions after sublethal PTC injury
are generally associated with altered F-actin organization.
Therefore, it is important to better understand the molecular
mechanisms involved in the regulation of the F-actin cytoskel-
eton and impaired cell adhesion after sublethal PTC injury.
Focal adhesions are the closest contact sites between cells
and the extracellular matrix. Focal adhesions are formed by a
complex network of cytoskeletal, adapter, and signaling pro-
teins. These include both structural (adapter) proteins such as
paxillin, talin, vinculin, and p130 Cas, and protein-tyrosine
kinases such as focal adhesion kinase (FAK), Pyk2, and Src, as
well as the mitogen-activated protein kinase (MAPK) family
members JNK and ERK. These proteins form a direct link
between the integrin cell adhesion receptors and the F-actin
network. Signaling mediated by the focal adhesion protein
complex is essential in various cellular processes, including cell
migration, proliferation, and survival. In vitro studies in
freshly isolated tubules as well as primary cultured renal PTC
and renal cell lines indicate an essential role of focal adhesion-
mediated signaling in the molecular mechanism of PTC injury,
which involves disruption of the focal adhesions and a reorga-
nization of the F-actin network (2). Cellular stress results in
activation of MAPK family members. Because these kinases
also localize at focal adhesions, the possibility exists that the
disturbances in cell adhesions after PTC injury are in part
because of activation of these kinases. So far, such a role of
MAPKs has not been studied.
The family of MAPKs consists of extracellular signal-regu-
lated kinases (ERKs), which can be activated downstream of
the growth factor receptor kinases, c-Jun N-terminal kinases
(JNK), and p38 MAPK that are particularly responsive to cel-
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lular stress conditions such as reactive oxygen species, heat
shock, and DNA damage (3). JNK and p38 have been impli-
cated in the cellular stress signaling in the kidney after acute
renal cell injury. Renal ischemia/reperfusion causes activation
of JNK, p38, and ERK (4–6), possibly as a direct consequence
of oxidative stress (4, 5). Also a variety of nephrotoxicants
causes the activation of JNK and p38 (7–9). In vitro as well as
in vivo studies using either antisense or pharmacological in-
hibitors suggest that sustained activation of JNK after PTC
injury promotes cell death (5, 10). Moreover, sub-lethal PTC
injury that results in pre-conditioning prevents the activation
of JNK and p38 after an additional ischemia/reperfusion insult
(11, 12); under these conditions, ERK activation was unaffected
(11). Although these data indicate that JNK activation pro-
motes cell death, the role of p38 activation in the control of PTC
apoptosis is largely unknown. Moreover, the exact mechanism
by which JNK and p38 affect PTC cell death is unclear. Both
JNK and p38 phosphorylate various transcription factors
thereby affecting gene expression and ultimately the protein
expression (13–16). Alternatively, JNK and p38 (in)directly
cause post-translational modification of other cellular proteins,
which may also affect the biological outcome of the cellular
stress response. For example, JNK can phosphorylate the anti-
apoptotic protein Bcl-2, thereby sensitizing cells for apoptosis
(17, 18). Alternatively, localization of JNK at focal adhesion
may result in the phosphorylation of FA-associated proteins
such as paxillin, thereby affecting focal adhesion turnover and
cell adhesion (19). In addition, p38 MAPKs activate the MAP-
KAP kinase 2, which phosphorylates other downstream tar-
gets, including small heat shock proteins such as Hsp27. Hsp27
and related proteins are known to affect the actin organization
as well as cell death, but their role in nephrotoxicant-induced
cell death is as yet unclear.
To study PTC injury, we use 1,2-dichlorovinyl-L-cysteine
(DCVC), which belongs to the group of nephrotoxic halogenated
alkene S-cysteine conjugates (20–24). Several characteristics
of DCVC make this an ideal model compound to study molec-
ular mechanisms of nephrotoxicity. DCVC is specifically taken
up by renal proximal tubular cells both in vitro and in vivo
where it is bio-activated by the renal cysteine conjugate -lyase
activity, resulting in the formation of reactive intermediates
that cause cell injury (23, 25). PTC injury is associated with
loss of focal adhesions and cell adhesion, which is followed by
caspase activation and the onset of apoptosis (20, 26, 27). Focal
adhesion-mediated signaling seems to be an important compo-
nent in the control of DCVC-induced apoptosis, because DCVC
causes the loss of FAK phosphorylation and thereby activity
and promotes the loss of focal adhesion organization (28). JNK
and p38 are also activated upon DCVC treatment. This allowed
us to study further the role and potential mechanism of these
stress kinases in the control of cellular stress-induced loss of
PTC adhesion in relation to the onset of apoptosis.
In the present study, we have used a proteomics approach
using two-dimensional difference gel electrophoresis (2D-
DIGE) (29–31) and mass spectrometry to identify proteins that
are either alternatively expressed or post-translationally mod-
ified in a MAPK-dependent manner after DCVC-induced injury
of PTC. Hsp27 was identified as the most prominent early
modified protein in the cellular stress response after DCVC
treatment of renal epithelial cells. This modification is related
to a p38-dependent phosphorylation of Hsp27. Both p38 activ-
ity and the phosphorylation of Hsp27 are implicated in the
protection of renal epithelial cells against a reorganization of
focal adhesions, activation of caspases, and the onset of apo-
ptosis caused by nephrotoxic cellular stress.
EXPERIMENTAL PROCEDURES
Materials—Dulbecco’s modified Eagle’s medium (DMEM), fetal calf
serum, penicillin/streptomycin, PBS, and trypsin/EDTA were from In-
vitrogen. The Cy-3 and Cy-5 N-hydroxysuccinimide ester dyes were
synthesized by Dr. Piers Gaffney (Ludwig Institute for Cancer Re-
search, London, UK). SyproRuby dye was from Molecular Probes; N,N-
9-diphenyl-p-phenylenediamine (DPPD) was from Aldrich; SP600125
and SB203580 were from Biomol. U0126 was from Promega. DCVC was
synthesized as described (32).
Cell Culture and Treatment Conditions—The porcine renal epithelial
cell line LLC-PK1 cells were maintained in DMEM supplemented with
10% (v/v) fetal calf serum and penicillin/streptomycin at 37 °C in a
humidified atmosphere of 95% air and 5% carbon dioxide. pkGFP and
pkGFP-FAT have been described previously (28). For preparation of
stable Hsp27 expressing cell lines, LLC-PK1 cells were transfected with
0.8 g of DNA of pcDNA3.1-Hsp27wt or pcDNA3.1-Hsp27-S19A/S82A
(further referred to as Hsp27-AA) (gift from T. Takano, McGill Univer-
sity (33)) using Lipofectamine Plus reagent according to the manufac-
turer’s procedures (Invitrogen). Stable transfectants were selected us-
ing 800 g/ml G418. Individual clones were picked and maintained in
complete medium containing 100 g/ml G418. Clones were analyzed for
Hsp27 expression using Western blotting and immunofluorescence. For
further experiments up to five stable cell lines were used per construct.
For experiments, cells were plated in either 6-cm collagen-coated dishes
or on collagen-coated glass coverslips in 24-well plates and allowed to
adhere overnight in complete culture medium. Cells were treated with
various concentrations of DCVC for the indicated times. All incubations
were performed in the presence of 20 M DPPD (10 mM stock in di-
methyl sulfoxide) to block the oxidative stress-dependent necrotic path-
way but allowing for the onset of apoptosis (22, 34).
Cell Cycle Analysis—Apoptosis was determined by cell cycle analysis.
Medium containing floating cells was collected. Adherent cells were
washed twice with PBS, 1 mM EDTA and trypsinized. Floating cells and
adherent cells that were trypsinized were pooled, centrifuged for 10 min
at 2000 rpm, and resuspended in 100 l of PBS followed by fixation in
90% ethanol (20 °C). Fixed cells were centrifuged and washed once
with PBS followed by resuspending in PBS/EDTA containing 7.5 M
propidium iodide and 10 g/ml RNase A. After 30 min at room temper-
ature, cells were analyzed by flow cytometry (FACSCalibur, BD Bio-
sciences). The amount of cells in sub-G0/G1 was calculated using the
Cellquest software (BD Biosciences).
Caspase Activity Measurement—Cells were scraped in medium and
collected by centrifugation together with floating cells. The cell pellet
was taken up in lysis buffer (10 mM HEPES, 40 mM -glycerophosphate,
50 mM NaCl, 2 mM MgCl2, and 5 mM EGTA) and subjected to three
cycles of freezing and thawing in liquid nitrogen. The suspension was
centrifuged at 13,000 rpm in a microcentrifuge for 30 min. The super-
natant was collected and used to determine the protein concentration
using the Bradford protein assay using IgG as a standard. Equal
amounts of cell protein (10 g) were used for measuring caspase activity
using Ac-DEVD-AMC as a substrate (25 M). AMC fluorescence was
followed in time using a fluorescence plate reader (HTS 7000 Bio assay
reader; PerkinElmer Life Sciences). Caspase activity was calculated as
pmol/mg of cell protein/min using AMC as a standard.
Western Blot Analysis-–For Western blot analysis, cells were washed
twice with PBS and lysed in ice-cold lysis buffer (50 mM HEPES, 150 mM
NaCl, 1% Nonidet P-40, 1 mM EDTA, pH 7.4) plus inhibitors (2 mM
4-(2-aminoethyl)benzenesulfonyl fluoride, 100 g/ml aprotinin, 17 g/ml
leupeptin, 1 g/ml pepstatin, 5 M fenvalerate, 5 M vanadate, and 1 M
okadaic acid) for 5 min. After lysis, cells were scraped and centrifuged for
5 min at 4 °C at 14,000 rpm. Protein concentrations were determined
using Coomassie protein assay reagent (Pierce). Equal amounts of protein
were separated by SDS-PAGE and transferred to polyvinylidene difluo-
ride membrane (Millipore). Blots were blocked with 5% (w/v) dry milk in
TBS-T (0.15 M NaCl, 50 mM Tris-HCl, and 0.05% (v/v) Tween 20) or 5%
(w/v) BSA in TBS-T overnight at 4 °C and probed with appropriate pri-
mary antibodies for 3 h at room temperature as follows: anti-cleaved
caspase-3 (rabbit polyclonal, 1:1000, Pharmingen), anti-FAK (monoclonal,
1 g/ml, BD Transduction Laboratories), anti-Tyr(P)397-FAK (polyclonal,
0.25 mg/ml, BioSource), anti-paxillin (monoclonal, 0.5 g/ml, BD Trans-
duction Laboratories), anti-Tyr(P)118-paxillin (polyclonal, 0.25 g/ml, Bio-
Source), anti-Hsp27 (rabbit polyclonal, 1 g/ml, Cell Signaling), anti-
Ser(P)82-Hsp27 (rabbjt polyclonal, 1 g/ml, Upstate Biotechnology, Inc.),
anti-p38 (rabbit polyclonal, 1 g/ml, Cell Signaling), anti-Thr(P)180/
Tyr(P)182-p38 (rabbit polyclonal, 1 g/ml, Cell Signaling), anti-JNK (rab-
bit polyclonal, 1 g/ml, Cell Signaling), and anti-Thr(P)183/Tyr(P)185-JNK
(rabbit polyclonal, 1 g/ml, Promega). Thereafter blots were incubated
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with horseradish peroxidase-conjugated secondary antibody (GE Health-
care) at 1:5000 dilution in TBS-T for 1 h at room temperature followed by
incubation with ECL Plus reagent (Amersham Biosciences) and detection
with a fluorescence imager (Typhoon 9400, Amersham Biosciences).
Preparation of Cell Extracts for 2D-DIGE—For 2D-DIGE experi-
ments, LLC-PK1 cells were plated in 10-cm dishes (2  106 cells) or
15-cm dishes ( 4  106 cells) in complete medium and allowed to grow
for 3 days. Cells were serum-starved overnight in phenol red and
serum-free DMEM. Thereafter, cells were treated with the indicated
concentrations of DCVC in serum/phenol red-free DMEM. Cells were
lysed in DIGE lysis buffer (8 M urea, 2 M thiourea, 4% (w/v) CHAPS, and
10 mM Tris, pH 8). The extracts were syringed several times followed by
a 20-min centrifugation (14,000 rpm, 4 °C). The protein concentration
was determined using Coomassie protein assay reagent (Pierce). Fresh
cell lysates were labeled for 30 min on ice, in the dark, with N-hydroxy-
succinimide ester derivatives of the cyanine dyes Cy-3 and Cy-5 (4
pmol/g protein) for DIGE analysis. Reactions were quenched with a
50-fold molar excess of lysine solution to dye for 10 min on ice. The
appropriate samples were mixed and reduced with 65 mM dithiothre-
itol. The final volume of the samples was made up to 350 l with DIGE
lysis buffer containing 1% each of ampholines/pharmalytes (GE Health-
care) and bromphenol blue. All samples were prepared and run
in triplicate.
Protein Separation by Two-dimensional Gel Electrophoresis, Gel Im-
aging, and Two-dimensional Blotting—For isoelectric focusing, immo-
bilized pH gradient strips pH 3–10 (GE Healthcare) were rehydrated
with the cyanine dye-labeled samples at room temperature in the dark
overnight. Isoelectric focusing was performed at 20 °C using a Mul-
tiphor II electrophoresis unit (GE Healthcare). A gradient of 300–3500
V was applied over 3 h followed by a constant voltage of 3500 V for 80
kV-h. Following focusing, the immobilized pH gradient strips were
equilibrated at room temperature for 15 min in equilibration buffer (6
M urea, 2% (w/v) SDS, 1% (w/v) dithiothreitol, 30% (v/v) glycerol, and 50
mM Tris, pH 6.8). The equilibrated, immobilized pH gradient strips
were transferred onto 18  20-cm 12% uniform polyacrylamide gels for
separation of proteins based on molecular weight. For DIGE analysis,
gels were bonded to low fluorescent glass plates using PlusOne bind/
silane solution (GEHealthcare). Each gel was run at 10 °C at a constant
current of 40 mA for 5 h in Protean II gel tanks (Bio-Rad). All two-
dimensional gels were scanned for Cy-3 and Cy-5 directly between low
fluorescent glass plates using a 2920 2D-Master Imager at the appro-
priate excitation and emission wavelengths (GE Healthcare). Bonded
gels were also post-stained with SyproRuby. Briefly, gels were fixed
overnight in 30% methanol, 7.5% acetic acid. After washing the gels
with water, total protein was detected by post-staining fixed gels with
SyproRuby (Molecular Probes) for at least 3 h. Post-stained gels were
washed with water to remove the excess of SyproRuby dye. Thereafter,
gels were scanned using the 2920 2D Imager at the appropriate exci-
tation and emission wavelengths (GE Healthcare). In some experi-
ments, unlabeled two-dimensional gels were transferred onto polyvi-
nylidene difluoride membranes overnight. Membranes were blocked
with 5% BSA followed by Western blotting essentially the same as
described above.
Image Analysis—All generated images were exported as .tif files for
further analysis of protein and phosphorylation profiles. The 2D-DIGE
images were analyzed using DeCyder software and are presented as
pseudo-colored and overlaid Cy-3 and Cy-5 images prepared using
Adobe Photoshop. Volumes of the spots were calculated using the dif-
ferential image analysis mode of DeCyder. Matched spots from tripli-
cate gels, which showed a statistically significant difference (p  0.05)
in spot volume after exposure of the cells to DCVC, had a 1.5 average
fold difference in spot volume and could be detected by SyproRuby
post-staining, were selected and excised from the DIGE gel using a
Syprot spot picker (GE Healthcare). Spots were collected in 96-well
plates and kept at 20 °C for subsequent protein identification by
mass spectrometry.
Mass Spectrometry—Peptide mass mapping by MALDI-TOF MS and
peptide sequencing by nano-HPLC-electrospray ionization-collision-in-
duced dissociation MS/MS was used for analysis of gel-separated pro-
teins (35). A standard protocol was used for in-gel proteolysis (36).
MALDI-MS spectra were recorded on a Reflex III (Bruker, Coventry,
UK) mass spectrometer using 2,5-dihydroxybenzoic acid as matrix and
internally calibrated using tryptic autolysis peptide ion signals. Nano-
HPLC-electrospray ionization-collision-induced dissociation MS/MS
was performed using an Ultimate HPLC (LC Packings, Amsterdam,
The Netherlands) with a PepMap C18 75-m inner diameter (LC Pack-
ings) column at a flow rate of 200 nl/min coupled to a Q-Tof (Micro-
mass, Wythenshawe, UK) mass spectrometer. Spectra were processed
by the manufacturers’ software and submitted to Mascot (37) and
ProteinProspector (38) data base search routines. Peptide mass toler-
ance was set to 100 ppm for protein identification by peptide mass
mapping. For peptide sequencing, the mass tolerance was set to 100
ppm for parent ion masses and 100 ppm or 100 millimass units for
fragment ion masses. In general, significant hits from Mascot searches
were considered as positive identifications. In the case of ProteinPros-
pector searches, protein identifications were selected as significant hits
by using criteria outlined in Ref. 39. A few MS/MS identifications were
verified or established by manual data interpretation (de novo
sequencing).
Immunofluorescence and Confocal Laser-scanning Microscopy—For
immunofluorescence studies, cells were cultured on collagen-coated
glass coverslips in 24-well dishes. Cells were fixed with 3.7% formalde-
hyde for 10 min followed by three washes with PBS. After cell perme-
abilization and blocking with PBS, 0.2% w/v Triton X-100, 0.5% w/v
BSA, pH 7.4 (PTB), cells were stained for Thr(P)183–Tyr(P)185-JNK
(Promega), Ser(P)82-Hsp27 (Cellular Signaling), FAK (clone 77, BD
Transduction Laboratories), Tyr(P)397-FAK (BioSource), paxillin (BD
Transduction Laboratories), and Tyr(P)118-paxillin (BioSource) diluted
in PTB. For secondary staining, Alexa488-labeled goat anti-mouse or
anti-rabbit (Molecular Probes) or Cy3-labeled goat anti-mouse or anti-
rabbit antibodies (Jackson Laboratories) were used. Cells were
mounted on glass slides using Aqua-Poly-Mount (Polysciences Inc.,
Warrington, PA). Cells were viewed using a Bio-Rad 2-photon confocal
laser scanning microscope, and images were processed with Adode
Photoshop 6.0.
Gel Filtration Experiments—pkHsp27 and pkAA-Hsp27 cells were
exposed to DCVC for 4 h and thereafter washed and lysed in 20 mM Tris,
pH 7.4, 20 mM NaCl, 5 mM MgCl2, 0.1 mM EDTA, and 0.1% Triton
X-100. The lysates were centrifuged twice at 18,000  g for 10 min, and
the supernatants were applied to a Superdex 75 or a Superdex 200
10/300 GL gel filtration column (APBiotech) equilibrated in lysis buffer
devoid of Triton X-100. Fractions of 1 ml were collected, and 50 l was
used for PAGE and Western blotting. Blots were stained for Hsp27. To
determine accurately the sizes of the oligomeric complexes, a gel filtra-
tion standard (Bio-Rad) was used, including thyroglobulin (670 kDa),
FIG. 1. Activation of stress kinases in DCVC-induced apop-
tosis. LLC-PK1 were treated with DCVC (0.25 mM) in Hanks’/HEPES
(H/H) or complete medium (CM) containing 10 M DPPD. After 4, 8, 12,
and 20 h of treatment with DCVC, apoptosis was determined using cell
cycle analysis (A), caspase-3 activity (B), or detection of active caspase-3
(act. casp-3) by Western blot analysis (C) as described under “Experi-
mental Procedures.” Activation of the stress kinases p38 and JNK was
determined by analysis of the phosphorylation status using Western
blotting (C). Data shown are the mean  S.E. (A and B) and are
representative of three independent experiments (C).
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bovine gamma-globulin (158 kDa), chicken ovalbumin (44 kDa), equine
myoglobin (17 kDa), and vitamin B12 (1.4 kDa).
RESULTS
Activation of Stress Kinases p38 and JNK Precedes Nephro-
toxicant-induced Apoptosis of LLC-PK1 Cells—To investigate
the activation of p38 and JNK in relation to chemically induced
injury of renal proximal tubular epithelial cells, LLC-PK1 cells
were treated with the model nephrotoxicant DCVC that causes
apoptosis of renal epithelial cells in a -lyase-dependent man-
ner (22, 34). The induction of apoptosis (Fig. 1A) in association
with the cleavage (Fig. 1C) and activation of caspase-3-like
activity (Fig. 1B) caused by DCVC was related to an activation
of JNK and p38 as determined by Western blotting using phos-
pho-state-specific antibodies (Fig. 1C). For our 2D-DIGE exper-
iment, we cultured cells in complete medium. Because amino
acids present in complete medium are known to compete for
uptake of DCVC and to alter the kinetics of DCVC-induced
apoptosis (40), we compared the cytotoxicity of DCVC in both
culture medium and our standard buffer for toxicant treat-
ment, Hanks’/HEPES. In culture medium, DCVC-induced apo-
ptosis was delayed and only started after 16 h of treatment
(Fig. 1, A and B). Likewise, the activation of JNK and p38 was
also delayed; p38 activity increased starting from 4 h, whereas
JNK was barely activated (Fig. 1C). A slight increase in
caspase-3 activity and onset of apoptosis was only evident after
20 h.
Proteomic Analysis of DCVC-induced Stress Response Using
2D-DIGE—JNK and p38 activation is associated with the phos-
phorylation of transcription factors such as Jun and ATF2,
thereby directly affecting the expression of stress-related pro-
teins (13). In addition, JNK and p38 can phosphorylate and
thereby modulate the activity of other proteins that by them-
selves may also affect the cell biological outcome of a stress
response. To investigate the early DCVC-induced events in
more detail, we used 2D-DIGE to compare accurately the
changes in the expression level and migration of proteins in
total cell lysates caused by DCVC in renal epithelial cells. For
proteomic analysis, we used cells that were exposed to DCVC
for 8 h. To compare accurately the protein profiles, triplicate
gels were made of both control and DCVC-treated LLC-PK1
cells. Lysates from control cells (labeled with Cy-3) and DCVC
cells (labeled with Cy-5) were run on the same gel, and differ-
ential expression analysis was performed (Fig. 2, A–C). Differ-
ences in protein profiles were detected and quantitated using
FIG. 2. 2D-DIGE analysis of control and DCVC-treated cells. LLC-PK1 cells were exposed to DCVC (0.25 mM) in phenol red-free DMEM
for 8 h. Protein samples for 2D-DIGE were prepared and run as described under “Experimental Procedures.” Control samples were labeled with
Cy3 dye (A) and DCVC-exposed samples with Cy5 dye (B). The merged image (C) shows differences in protein expression between control (red) and
DCVC (blue). Protein expression patterns were compared using DeCyder software (D). The 1.5 average fold differences  S.D. were calculated
for three different gels (n  3) (E).
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the differential in-gel analysis mode of DeCyder software and
are presented as overlaid images (Fig. 2C; Cy-3, control shown
in red, and Cy-5, DCVC-treated shown in blue). By using De-
Cyder, the Cy-3 and Cy-5 gel images were normalized and
compared with detectable differences in spot volume (protein
abundance). For each gel, DeCyder generates a histogram
showing protein expression differences between control (Cy-3-
labeled) and DCVC-treated (Cy-5-labeled) cells at a 1.5 aver-
age fold difference cut-off (Fig. 2D). Differences found on all
three gels were compared, and the data were filtered to reveal
significant changes in protein abundance (p  0.05). At a 1.5
average fold difference cut-off, we could detect 23 differentially
expressed protein spots after DCVC treatment of LLC-PK1
cells, of which nine were down-regulated (Fig. 2E). Gels were
post-stained with SyproRuby, and all detectable changing spots
were selected for identification by mass spectrometric analysis
(see “Experimental Procedures”). Of the 23 differentially ex-
pressed protein spots, 15 positive identifications were obtained,
representing a total of 9 different proteins (Table I), including
heat shock protein 27 (Hsp27), -b-crystallin, glutathione
transferase omega 1, proteasome subunit -type 1, pyruvate
dehydrogenase, nuclear chloride ion channel protein, cofilin,
aconitase hydratase, and voltage-dependent anion channel. Of
the positively identified proteins, Hsp27 was the most abun-
dant protein and was identified in several different spots. Be-
cause Hsp27 has also been linked to acute renal failure in vivo
(11), we focused on this protein for further verification as well
as its role in the mechanism of cytotoxicity.
Mobility Shift of Hsp27 after DCVC Exposure Is Related to
Phosphorylation—Five different protein spots were identified
as Hsp27 (Table I). To verify the identity of these spots, we
performed two-dimensional Western blotting for Hsp27 using
specific antibodies; all spots stained positive for Hsp27 (Fig.
3C). Heat shock genes, including Hsp70, are up-regulated after
exposure to nephrotoxic cysteine conjugates, which is directly
related to activation of heat shock factor 1 (41. 42). However, no
effect of DCVC was observed on the total expression level of
Hsp27 (Fig. 3D). In addition, other heat shock proteins, includ-
ing Hsp60, Hsp70, and Hsp90, were also not yet up-regulated
(data not shown). Treatment of the LLC-PK1 cells resulted in
the activation of the stress kinases p38 and JNK (Fig. 1). Hsp27
is known to be phosphorylated on serine residues 15, 78, and 82
by a downstream target of p38, the MAPK-associated protein
kinase (MAPKAPK)-2 (43). This suggested the possible phos-
phorylation of Hsp27 on these serine residues. Indeed, MS/MS
peptide identification revealed the phosphorylation of the ser-
ine residue that corresponds to Ser82 in human Hsp27 as well
as other species (Fig. 3A). Moreover, DCVC caused a time- and
concentration-dependent Ser82 phosphorylation of Hsp27 as
determined by one-dimensional Western blotting using a Ser82
phospho-specific antibody (Fig. 3E). DCVC-induced phospho-
Ser82-Hsp27 had a cytosolic localization; however, in some cells
it was highly concentrated with no apparent organelle co-local-
ization (Fig. 3F). This was not observed for the Hsp27 alone,
suggesting a specific concentration of the phosphorylated form
in these regions (data not shown). The phospho-Ser82-Hsp27
was also observed on the two-dimensional Western blots; pos-
itive staining corresponded with the acidic Hsp27 spots except
for the spot with the highest pI shift (Fig. 2C, spot 1). Despite
the fact that this spot did not react strongly with both the
Hsp27 and phospho-Hsp27 antibody on two-dimensional West-
ern blots, MS/MS analysis positively identified this spot as
Ser(P)82-Hsp27 (see Table I and Fig. 3A). In conclusion, the
data identify Hsp27 as the major early modified cellular pro-
tein after treatment with DCVC, which is related, in part, to
the phosphorylation of serine residue 82.
p38 and JNK Activation Differentially Regulate Hsp27 Phos-
phorylation in Association with Cell Adhesion—Treatment
with DCVC caused the activation of both p38 and JNK (Fig. 1).
Because Hsp27 is phosphorylated on Ser82 by MAPKAPK-2, a
target of p38, we next determined the involvement of p38 in
this phosphorylation process as well as its regulation by JNK.
Pharmacological inhibition of p38 with SB203580 inhibited
DCVC-induced phosphorylation of Hsp27, without affecting the
activity of JNK, as determined by analysis of the phosphoryl-
ation of the transcription factor c-Jun (Fig. 4A). Inhibition of
JNK activity with SP600125 prevented the phosphorylation of
c-Jun but had little effect on Hsp27 phosphorylation (Fig. 4A).
However, SP600125 did cause a higher percentage of cells with
concentrated phospho-Hsp27; moreover, under these condi-
tions Ser(P)82-Hsp27 co-localized in part to the F-actin network
(data not shown). This was not observed in cells that were
exposed to SP600125 alone. These data indicate a differential
role for p38 and JNK in the control of Hsp27 phosphorylation,
possibly in relation to F-actin network reorganization after
stress induced by cytotoxicants. Therefore, we next wanted to
determine the relative importance of these different stress
kinases in the cellular response to DCVC. Nephrotoxic cysteine
conjugates, including DCVC, affect the adhesion of renal epi-
thelial cells to the extracellular matrix (20). This is associated
TABLE I
Summary of the MS results of significantly differentially changed spots
Spot no. Protein name Mr pI ID no.
Average fold difference
(S.D.) (DCVC/ control)
Spot intensitya
 105 ID
b
%
1 Heat shock protein 27 22,939 6.23 P42929 12.7 (2.7) 31.7 6:25
4 -b-Crystallin 20,129 6.76 JC5971 4.6 (0.9) 3.47 9:55
6 Glutathione transferase omega 1 27,491 6.36 Q9N1F5 4.2 (0.2) 9.55 6:27
7 Heat shock protein 27 22,939 6.23 P42929 4.0 (0.3) 53.5 6:23
8 Proteasome subunit, -type 1 29,579 6.15 13543551 3.2 (0.3) 4.75 10:51
10 Heat shock protein 27 22,939 6.23 P42929 2.6 (0.3) 5.36 29:51
12 Pyruvate dehydrogenase subunit  40,342 6.78 1917268A 2.1 (0.3) 6.58 11:28
14 Nuclear chloride ion channel
protein
26,924 5.02 AAC25675 1.9 (0.5) 5.58 5:34
15 Aconitase hydratase 85,762 8.24 P16276 1.5 (0.1) 15.1 20:31
16 -b-Crystallin 20,129 6.76 JC5971 1.6 (0.3) 18.1 8:43
17 Cofilin 18,519 8.16 P10668 1.8 (0.8) 28.1 8:57
19 Voltage-dependent anion channel 33,372 7.51 Xp032438 2.0 (0.2) 12.4 15:61
21 Heat shock protein 27 22,939 6.23 P42929 3.0 (0.3) 34.3 6:20
28 Heat shock protein 27 22,939 6.23 P42929 3.3 (0.2) 8.21 6:32
22 Glutathione transferase omega 1 27,491 6.36 Q9N1F5 3.8 (1.8) 6.42 8:32
a Calculated spot intensity of up-regulated proteins (Cy-5 intensity) and down-regulated proteins (Cy-3 intensity) after DCVC treatment.
b Number of matched peptides and their combined sequence coverage for the identified protein.
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with reorganization of the F-actin cytoskeletal network, loss of
focal adhesions, and dephosphorylation of several components
that are associated with focal adhesions (20, 26). Treatment of
LLC-PK1 cells with DCVC alone caused a slight increase in
loss of cell adhesion after 8 h (Fig. 4B). SB203580 caused a
drastic increase of the percentage of cells that detached. In
contrast, SP600125 prevented DCVC-induced cell detachment
almost completely (Fig. 4B). Similar effects of inhibition of
either p38 or JNK on DCVC-mediated changes in cell adhesion
were also observed in primary cultured rat proximal tubular
cells treated with DCVC (data not shown). Together, these data
suggest an essential role for p38 but not JNK in the control of
Hsp27 phosphorylation in association with the regulation of
cell adhesion after cellular stress.
Increased Association of Activated JNK at Focal Adhesions in
Association with Regulation of Focal Adhesion Turnover—En-
gagement between the extracellular matrix and the integrin
cell adhesion receptors resulted in formation of so-called focal
adhesions (FAs), the closest contact sites between cells and the
extracellular matrix. FAs are large protein complexes that link
the integrin receptors to the cytoskeletal network. Various
cytoskeletal (regulating) proteins, adapter proteins, and signal
transduction proteins are concentrated at FAs that together
control a variety of cell biological processes such as cell migra-
FIG. 3. DCVC causes phosphorylation of Hsp27 on serine residue 82. MS/MS analysis of a tryptic peptide derived from Hsp27 (spot 1)
revealed phosphorylation on a Ser residue. A, asterisks indicate a loss of phosphoric acid. Alignment of the phosphopeptide pSSGVEIKKTADR with
human, dog, mouse, and rat sequences (B). Two-dimensional Western blotting was performed as described under “Experimental Procedures” to
confirm the Hsp27 mobility shift and phosphorylation on Ser82 after DCVC (0.25 mM) treatment. Two-dimensional blots were probed with Hsp27
and Ser(P)82-Hsp27 antibody as described under “Experimental Procedures.” C, LLC-PK1 cells were treated with DCVC (0.25 or 0.5 mM) in
Hanks’/HEPES buffer for the indicated times, and the effects on Hsp27 expression (D) and phosphorylation (E) were analyzed by regular Western
blotting. Hsp27 phosphorylation was also evaluated by immunofluorescence. F, data shown are representative of three independent experiments.
IB, immunoblot.
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tion, proliferation, and survival. Also JNK is associated with
FAs and activated upon cell adhesions (19, 44). Inhibition of
Hsp27 phosphorylation with an inhibitor of p38 increased
DCVC-induced cell detachment. Since under these conditions
JNK activity was maintained and since inhibition of JNK pre-
vented loss of cell adhesion, we reasoned that an increased
activity of JNK at FAs is likely to be involved in the cell
detachment caused by DCVC. Immunofluorescence analysis
indicated not only an overall increase in levels of phosphoryl-
ated JNK after DCVC treatment, as expected based onWestern
blotting data (Figs. 1 and 4A), but also concentrated levels of
phospho-JNK at sites that co-localized with the FA-associated
adapter protein paxillin (Fig. 5). To rule out the possibility that
the detection of phospho-JNK at FAs was related to the slight
cross-reactivity of the antibody with the activated form of
ERK1, cells were also treated with a selective inhibitor of
MEK1, an upstream activator of ERKs. U0126 prevented ERK
phosphorylation but did not affect JNK phosphorylation or the
accumulation of phospho-JNK at FAs as determined by West-
ern blotting and immunofluorescence, respectively (data not
shown). Because active JNK is associated with FAs, we rea-
soned that JNK activity might be involved in the reorganiza-
tion of FAs and oppose the action of p38. Under DCVC condi-
tions, inhibition of JNK with SP600125 also resulted in
increased association of Ser(P)82-Hsp27 with punctate struc-
tures and F-actin (data not shown). Therefore, a potential role
for JNK in FA turnover after cellular stress might indirectly be
related to p38 activity. We determined the effect of inhibition of
JNK and p38 on FA reorganization after DCVC treatment by
evaluating the effect on paxillin and phosphorylated paxillin
(Tyr(P)118-paxillin) localization. DCVC itself caused a reorga-
nization of FAs (i.e. paxillin staining) as well as F-actin struc-
ture after 4 h of treatment, which preceded the onset of apo-
ptosis and cell detachment (Fig. 4C). This is in accordance with
our previous findings in primary cultured rat proximal tubular
cells (20). This reorganization was more prominent when cells
FIG. 4. p38 and JNK regulate Hsp27 phosphorylation and cell adhesion. LLC-PK1 cells were treated with DCVC (0.25 or 0.5 mM) in the
absence or presence of the p38 inhibitor SB203580 (20 M) or the JNK inhibitor SP600125 (20 M) in Hanks’/HEPES buffer. After 4 h samples were
taken for Western blotting to determine activation and phosphorylation of c-Jun, JNK, Hsp27, and p38. A, at the same time, point cell adhesion
was evaluated by phase-contrast microscopy. B, for evaluation of focal adhesion reorganization, LLC-PK1 cells were cultured on collagen-coated
coverslips, fixed, and double-stained for Tyr(P)118-paxillin (green) and paxillin (red) followed by confocal laser-scanning microscopy analysis. C,
data shown are representative of three independent experiments.
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were treated with DCVC in the presence of SB203580, indicat-
ing a role of p38 in the control of focal adhesion organization; no
clear effect of SP600125 on the DCVC-induced reorganization
of focal adhesions was observed (Fig. 4C). FAK is an important
player in the control of FA and its downstream signaling, which
is dependent on its phosphorylation at tyrosine residue 397.
Because DCVC causes the dephosphorylation of this residue
prior to onset of apoptosis (20), we also evaluated a possible
differential effect of SB203580 and SP600125 on FAK phospho-
rylation. However, no protection against FAK dephosphoryl-
ation by DCVC was observed after inhibition of either p38 or
JNK (data not shown).
Recent data indicate the direct association between MEK
kinase 1 and JASP1 (JNK/stress-activated protein kinase-as-
sociated protein 1) with FAK. Also, JNK can directly phospho-
rylate paxillin, an FA-associated adapter protein (19). There-
fore, we hypothesized that FAK may be an important factor in
the activation of JNK and possibly also activation of p38. To
investigate this further, we used LLC-PK1 cells that overex-
press a GFP-tagged dominant negative-acting deletion mutant
of FAK (GFP-FAT) that lacks the N terminus. Overexpression
of GFP-FAT, which competed for the localization of endogenous
FAK at focal adhesion (28, 45), accelerated DCVC-induced de-
phosphorylation of FAK (Fig. 6A). DCVC caused an equal ac-
tivation of both JNK and p38 in both pkGFP and pkGFP-FAT
cells (Fig. 6A). In addition, no difference in the phosphorylation
of Hsp27 and c-Jun was observed after DCVC treatment. Ac-
tive phosphorylated JNK was associated with focal adhesions
in pkGFP cells; however, no clear co-localization between phos-
pho-JNK and paxillin was observed in pkGFP-FAT cells (Fig.
6B). After DCVC treatment, increased levels of active JNK
were associated with FAs in pkGFP cells, but still no phospho-
JNK associated with FAs in pkGFP-FAT cells (Fig. 6C). To-
gether, these data indicate that FAK is not involved in the
activation of JNK and p38 caused by DCVC, as well as the
phosphorylation of Hsp27. Moreover, phospho-JNK association
with FAs is not a prerequisite for c-Jun phosphorylation.
Differential Regulation of Apoptosis by p38 and JNK—Our
earlier work indicated that the reorganization of FAs in asso-
ciation with cell detachment is important for the control of
DCVC-induced apoptosis. This suggested that also inhibition of
p38 by SB203580, which resulted in accelerated loss of FAs in
association with cell detachment, would increase the apoptosis
caused by DCVC. Inhibition of JNK with SP600125 would have
the opposite effect. Indeed, SB203580 increased the percentage
of apoptotic cells (Fig. 7A). This was associated with a higher
percentage of cells that were positive for active caspase-3 as
determined by immunofluorescence (Fig. 7B) as well as an
increase in total cellular caspase-3-like activity (Fig. 7C). In
contrast, SP600125, which prevented DCVC-induced cell de-
tachment, also prevented the onset of apoptosis (Fig. 7). To-
gether these data suggest a relationship between stress kinase-
mediated cytoskeletal reorganization loss of FA and apoptosis.
p38-mediated Hsp27 Phosphorylation Is Associated with Pro-
tection against FA Reorganization and Apoptosis—The above
findings indicate an important role for p38 and JNK in the
regulation of cell adhesion and apoptosis. Because Hsp27 was
identified as the most prominent early modified protein in
association with p38-dependent phosphorylation, we next in-
vestigated whether Hsp27 plays a crucial role in the regulation
of FAs and apoptosis after cellular stress. For this purpose we
created LLC-PK1 cell lines that stably overexpress either wild
type Hsp27 (pkHsp27) or mutant Hsp27 that has Ser to Ala
mutations at residues 15 and 82, the two prominent MAPKAP
kinase phosphorylation sites (pkAA-Hsp27). Both pkHsp27
and pkAA-Hsp27 cell lines had 5–10-fold higher levels of
Hsp27 compared with pkNeo control cell lines (Fig. 8A). No
effect of either Hsp27 or AA-Hsp27 was observed on cell pro-
liferation (data not shown). Next, we determined the effect of
overexpression of wild type Hsp27 and AA-Hsp27 on p38 and
JNK activation as well as the phosphorylation of both Hsp27
and c-Jun after treatment with DCVC. DCVC caused a similar
activation of p38 in pkNeo, pkHsp27, and pkAA-Hsp27 cells.
p38 activation was associated with increased levels of P-Hsp27
in pkHsp27 cells, which correlated with the increased expres-
sion of Hsp27 in these cells. No further increase in Hsp27
phosphorylation was observed in pkAA-Hsp27 cells compared
with pkNeo control cells. JNK activation and c-Jun phospho-
rylation were comparable in all three cell lines. Next, we de-
termined the effect on the induction of apoptosis. Overexpres-
sion of Hsp27 did not affect the percentage of apoptosis
compared with Neo control cells (Fig. 8C). In contrast, overex-
pression of AA-Hsp27-sensitized LLC-PK1 cells toward DCVC
induced apoptosis. To determine whether this was directly
related to activation of caspases, we also determined caspase-3
like activity. Although DCVC caused activation of caspase-3-
like activity in pkHsp27 cells to almost a similar extent as in
pkNeo cells, a more than 2-fold increase in caspase-3 activity
was observed in pkAA-Hsp27 cells. Caspase activity in un-
treated cells was similar in all three cell lines.
The above data indicate that activation of p38 is essential in
the maintenance of focal adhesion organization after cellular
stress and that p38 inhibition promotes apoptosis (Figs. 4, 5,
and 7). Because Hsp27 is a downstream substrate of the p38-
controlled MAPKAP kinase, we wondered whether p38-medi-
ated Hsp27 phosphorylation controls focal adhesion organiza-
tion after DCVC treatment. First, we evaluated the effect of
DCVC on FAK phosphorylation. Treatment of pkNeo,
pkHsp27, and pkAA-Hsp27 cells resulted in similar levels of
dephosphorylation of FAK as determined by Western blotting
(Fig. 8A). We also evaluated the organization of focal adhesions
in these cells. Under normal conditions phosphorylated FAK,
which specifically localizes at focal adhesions, was present at
focal adhesion in the cell periphery in all three different cell
FIG. 5. Increased localization of phospho-JNK at focal adhe-
sions after DCVC treatment. LLC-PK1 cells were treated with
DCVC (0.25 or 0.5 mM) as described in Fig. 4. After 4 h cells were fixed
and immunostained for phospho-JNK and paxillin to determine co-
localization at focal adhesions. Images were generated using confocal
laser-scanning microscopy. Shown is P-JNK in the top panels, paxillin
in middle panels, and merge images in the bottom panels (P-JNK in
green and paxillin in red; co-localization is orange to yellow). Data are
representative of three independent experiments.
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lines, whereas DCVC caused a reorganization of focal adhe-
sions to the more central regions of the pkNeo and pkHsp27
cells; these focal adhesions were still clearly visible (Fig. 8E).
However, in pkAA-Hsp27 cells DCVC caused a more drastic
reorganization of focal adhesions; phospho-FAK localization
was no longer concentrated, and paxillin localization was more
FIG. 6. Effect of GFP-FAT overexpression on DCVC-induced activation of the stress kinases p38, JNK, and Hsp27 phosphorylation.
pkGFP and pkGFP-FAT cells were treated with DCVC (0.25 or 0.5 mM) as indicated in Fig. 4. After 4 h, samples were taken and analyzed for
phosphorylation of FAK, Hsp27, p38, c-Jun, and JNK using Western blotting (A). Both control (B) and DCVC-exposed (C) pkGFP and pkGFP-FAT
cells were fixed after 4 h followed by immunostaining for paxillin (Cy3) and P-JNK (Cy5) and analysis by confocal laser-scanning microscopy
analysis of GFP, paxillin, and P-JNK. Note that insets in the panels of paxillin and P-JNK are enlargements of the same images. Data shown are
representative for two different pkGFP and pkGFP-FAT clones observed in three different experiments.
FIG. 7.Modulation of DCVC-induced caspase 3 activation and apoptosis by p38 and JNK. LLC-PK 1 cells were exposed to DCVC (0.25
or 0.5 mM) with or without the p38 inhibitor SB203580 (20 M) or the JNK inhibitor SP600125 (20 M) for 8 h as described in Fig. 4. Apoptosis
was determined by counting the number of cells with a fragmented nucleus using Hoechst staining (A) or the percentage of cells that was positive
for active caspase-3. B, in addition, caspase-3 activity (C) was determined as described under “Experimental Procedures.” Data shown are the
mean  S.E. of three independent experiments (n  3).
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FIG. 8.Overexpression of phosphorylationmutant Hsp27 enhances DCVC-induced apoptosis. pkNeo, pkHsp27, and pkAA-Hsp27 were
analyzed for Hsp27 expression by Western blotting as described under “Experimental Procedures.” A and B, pkNeo, pkHsp27, and pkAA-Hsp27
were exposed to DCVC (0.25 mM) as described in Fig. 4, and after 8 h samples were taken and analyzed for phosphorylation of Hsp27, FAK, p38,
and JNK using Western blotting. B, 12 h after treatment, the percentage apoptosis was determined by using cell cycle analysis (C), and caspase-3
activity was determined by measuring DEVDase activity (D) as described under “Experimental Procedures.” Data shown are the mean  S.D. of
three (pkNeo) or five (pkHsp27 and pkAA-Hsp27) independent clones (n  3–5). Data are representative of two independent experiments. E, to
determine the effect of pkAA-Hsp27 on focal adhesion reorganization after DCVC treatment, cells were fixed and immunostained for paxillin
(green) and Tyr(P)397-FAK (red) followed by confocal laser-scanning microscopy analysis. Images shown are from pkHsp27 (clone 4) and
pkAA-Hsp27 (clone 20) and are representative for the effects observed in the other pkHsp27 and pkAA-Hsp27 clones in two independent
experiments.
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distributed over the entire cell (Fig. 8E). Together, these data
indicate an essential role for Hsp27 phosphorylation in the
control of cellular stress-induced apoptosis in renal epithelial
cells in close association with maintenance of cellular-extracel-
lular matrix adhesion complexes.
Oligomeric Organization of Hsp27 Is Not Affected in pkAA-
Hsp27 Cells—Small heat shock proteins (small Hsp, including
Hsp27) can form oligomeric complexes with molecular com-
plexes ranging from around 100 to 800 kDa. Phosphorylation of
small heat shock proteins may lead to changes in the oligomeric
organization resulting in smaller oligomers, which are respon-
sible for stabilization of the actin filaments, and larger oli-
gomers, which may act as chaperones thereby protecting
against cellular stress (46–48). To study the influence of
DCVC-induced changes in Hsp27 phosphorylation on oligo-
meric organization of Hsp27, we analyzed pkHsp27 and pkAA-
Hsp27 cells treated with DCVC for oligomeric sizes by size
exclusion gel filtration using either Superdex 75 or Superdex
200 columns. Our analysis shows that Hsp27 is present as
large oligomers (800–600 kDa) as well as small oligomers
(200–100 kDa) and monomers (27 kDa) in both cell lines either
treated or untreated (Fig. 9A). In pkHsp27 cells, DCVC caused
a slight shift in the levels of around 800–600 kDa (fractions 11
and 12) toward the 200–100-kDa (fractions 14 and 15) com-
plexes; no increase in monomeric Hsp27 (fractions 19 and 20)
was observed. In pkAA-Hsp27 cells this DCVC-induced shift
did not occur. To calculate more precisely the relative amount
of monomeric Hsp27 compared with the oligomeric forms of
Hsp27, we used a Superdex 75 column. With this column we
were able to obtain more concentrated fractions; all the mono-
meric Hsp27 proteins were eluted in one single fraction (frac-
tion 10), whereas all the oligomeric forms were eluted in frac-
tions 8 and 9. For both control as well as DCVC-treated cells,
we observed 40% of Hsp27 protein in the oligomeric fractions
(lanes 8 and 9) and 30% in the fraction containing monomer
Hsp27 (lane 8, Fig. 9B). No difference was observed between
pkHsp27 or pkAA-Hsp27 cells, further supporting our findings
of the Superdex 200 column that no major shift occurred in the
levels of monomeric Hsp27. It would be relevant to determine
in which fraction the phosphorylated form of Hsp27 is present,
which of course can only be observed in the pkHsp27 and not
the pkAA-Hsp27 cells. Unfortunately, it was not possible to
detect phosphorylated Hsp27 in the samples most likely be-
cause of the dilution of the samples of the cell lysate after size
exclusion chromatography and/or limited sensitivity of the
Ser(P)82-Hsp27 antibody staining. These data suggest that sub-
tle changes in the size of oligomeric complexes rather than the
levels of monomeric Hsp27 may determine the differences be-
tween pkHsp27 and pkAA-Hsp27 cells with respect to DCVC-
induced cytotoxicity.
DISCUSSION
In the present study we have used 2D-DIGE and mass spec-
trometry to identify proteins that are differentially expressed
and/or post-translationally modified prior to the onset of renal
proximal tubular cell apoptosis caused by the nephrotoxic cys-
teine conjugate DCVC. By using this and other approaches, we
were able do the following: 1) to identify nine different proteins
that play a role in the regulation of the actin cytoskeletal net-
work, cellular metabolism, and cellular stress responses; 2) to
define that Hsp27 is a protein that is affected most after DCVC-
induced renal cell injury (Hsp27 changes are related to increased
phosphorylation of Hsp27 in a p38-dependent manner); and 3) to
determine the importance of Hsp27 phosphorylation in suppres-
sion of the onset of renal cell apoptosis. These effects of Hsp27
appear to be related to control of focal adhesion turnover.
As mentioned, we were able to identify proteins that may
play a role in DCVC-induced cytotoxicity. It should be stressed,
however, that the conditions we used for our proteomics ap-
proach were mild; cells were treated with DCVC in culture
medium, which resulted in the onset of cytotoxicity only after
24 h. The reduced cytotoxicity of DCVC under these conditions
is most likely because of the reduced uptake of DCVC by
cysteine carriers due to the presence of L-cysteine in the me-
dium. Although our findings may therefore not reflect typical
exposure conditions for DCVC to determine the mechanism of
toxicity, the identified proteins are most likely the first pro-
teins that are modified and therefore crucial in the early
phases of cellular injury caused by DCVC. Two of the proteins
that we identified are involved in cellular metabolism, aconi-
tase hydratase and the  subunit of pyruvate dehydrogenase.
Aconitase, which is located in the mitochondrial matrix, was
recently identified as a direct target for covalent modification
by a structural and mechanistically similar nephrotoxic cys-
teine conjugate, S-(1,1,2,2)-tetrafluoroethyl-L-cysteine (TFEC),
which is also metabolized by renal proximal tubular cells in a
-lyase-dependent manner resulting in the formation of a
thioalkylating reactive intermediate. In fact, aconitase seems
part of a functional multienzyme complex that also contains
other proteins that are directly modified by TFEC, including
two subunits of -ketoglutarate-dehydrogenase, lipoamide suc-
cinyltransferase and dihydrolipoamide dehydrogenase. In the
2D-DIGE experiments, aconitase was present in two protein
spots with identical molecular weights but with different pI
values as determined by two-dimensional Western blotting
with aconitase antibodies (data not shown). DCVC caused the
formation of two additional acidic aconitase spots and a de-
crease in the level of the most prominent basic aconitase spot.
These differences in the pI values of aconitase are possibly due
to the modification of the labile 4Fe-4S clusters in aconitase
that are required in the dehydration-rehydration of citrate to
isocitrate in the Krebs cycle. Likewise, modification of aconi-
tase by cysteine conjugates may affect these Fe-S clusters and,
thereby, the pI characteristics of the protein and possibly the
enzyme activity. Indeed, modification of aconitase by TFEC
causes an inhibition of aconitase enzyme activity (49). Al-
though we do not know the exact reason for the changes in
protein spots in our two-dimensional gels (i.e. direct covalent
modification, altered transcription/translation, or phosphoryl-
ation), the identified proteins fit with the current understand-
ing that nephrotoxic cysteine conjugates directly affect mito-
chondrial function.
We also identified several proteins that are important in the
control of the actin cytoskeletal network, including cofilin,
Hsp27, and -b-crystallin. This supports our previous finding
that DCVC causes drastic changes in the organization of the
F-actin network (22). These changes may well be related to
alterations in the expression and/or activity of cofilin. Also
Hsp27 and -b-crystallin have been associated with the regu-
lation of F-actin network organization, although this has not
been shown for renal epithelial cells.
The most prominent changes after cellular stress in LLC-
PK1 cells were observed in Hsp27, which belongs to the family
of small heat shock proteins that also includes -B-crystallin.
No difference in the total cellular level of Hsp27 was observed
after DCVC treatment. Instead, changes in the two-dimen-
sional protein profile of Hsp27 were primarily due to increased
phosphorylation of Hsp27, which explained a pI shift to the
acidic region. By using mass spectrometry, we identified phos-
phorylation of Hsp27 on Ser82. Although phosphorylation of
this residue was verified by both Western blotting and immu-
nofluorescence using phospho-state-specific antibodies against
this phosphorylated residue, it did not fully explain the multi-
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FIG. 9. Effect of DCVC on Hsp27 oligomerization in pkHsp27 and pkAA-Hsp27 cells. pkHsp27 and pkAA-Hsp27 were exposed to 0.25 mM
DCVC for 4 h, and cell lysates were prepared as described under “Experimental Procedures.” The degree of oligomerization was determined using
size exclusion gel filtration on a Superdex 200 (A) or Superdex 75 column (B) (AP Biotech), both calibrated with a gel filtration standard (Bio-Rad),
including the marker proteins thyroglobulin (670 kDa), bovine gamma-globulin (158 kDa), chicken ovalbumin (44 kDa), equine myoglobin (17 kDa),
and vitamin B12 (1.4 kDa). 50 l of total cell lysate (0.2 mg of protein) was applied to each column, and fractions of 1 ml were collected. The solid
line shows the relative absorbance (280 nm) of proteins in the total cell lysate, and the dashed line shows the 280 nm chromatogram of all marker
proteins. The presence of Hsp27 in the fractions eluted of the column was detected by immunoblotting (50 l per lane for each fraction) using an
Hsp27 antibody (insets). The arrows indicate which fractions contain Hsp27 oligomers and monomers.
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ple Hsp27 spots that were identified by 2D-DIGE. Hsp27 is also
phosphorylated on Ser15 and Ser78 in LLC-PK1 cells, which
could account for the additional spots observed in the two-
dimensional Western blots. Regardless of the exact modifica-
tion of Hsp27 by phosphorylation, stable overexpression in
LLC-PK1 cells of a Ser15 3 Ala/Ser82 3 Ala-Hsp27 mutant
accelerated the onset of apoptosis caused by DCVC, underscor-
ing the role of these two Hsp27 modifications in the control of
renal cell death. Although adenovirus-mediated overexpression
of wild type Hsp27 also inhibits cell death of LLC-PK1 cells
caused by either oxidative stress or ATP depletion (12), in our
hands overexpression of wild type Hsp27 itself did not provide
cytoprotection. Most likely the phosphorylation of endogenous
Hsp27 is already sufficient to provide protection, and the phos-
phorylation-defective mutant Hsp27 acts as a dominant nega-
tive for the function of endogenous Hsp27. Alternatively, ade-
novirus-mediated transduction of Hsp27 results in far higher
levels of Hsp27 than in our stable transfected cell lines.
Because phosphorylation of Hsp27 may influence the oligo-
meric organization of Hsp27, thereby affecting its stress-pro-
tective chaperone function, we determined the effect of inhibi-
tion of Hsp27 phosphorylation on the formation of oligomeric
complexes (50, 51). Replacement of Ser15 and Ser82 by Ala
slightly affected the size of large oligomers of Hsp27 in DCVC-
treated cells (Fig. 9A); however, no change in the levels of
monomeric Hsp27 was observed. Mehlen et al. (46) showed that
a triple Ser mutant leads to the formation of large aggregates
compared with wild type Hsp27, whereas only a triple and not
a mono- or double phospho-mimicking mutant resulted in a
significant decrease in large oligomers (47). We used a double
mutant in our studies that already sensitized cells for the onset
of apoptosis. Because phosphorylation of Hsp27 is very rapid
and transient, newly formed oligomers are rapidly created
thereby enhancing the chaperone function of Hsp27. The dif-
ferences in apoptotic cell death between pkHsp27 and pkAA-
Hsp27 cells may well be due to a slower turnover of large
oligomers in mutant cells resulting in higher levels of unfolded
proteins, which is supported by our data in Fig. 9A. In addition,
phosphorylated, monomeric forms of Hsp27 may protect cells
against apoptosis by stabilizing the cytoskeletal network (48).
Although the amounts of Hsp27 monomers did not differ be-
tween pkHsp27 and pkAA-Hsp27 cells (Fig. 9B), the phospho-
rylation status does differ. The unphosphorylated Hsp27 in the
pkAA-Hsp27 cells is not capable of F-actin stabilization and
protection of focal adhesion reorganization resulting in en-
hanced apoptotic cell death.
Phosphorylation of Hsp27 on Ser82 is mediated by MAPKAP
kinase 2, which is activated by p38. In our hands, the Ser82
phosphorylation of Hsp27 was dependent on p38 activity be-
cause SB203580 inhibited it, although some phosphorylated
Hsp27 could still be observed. This remaining phosphorylation
of Hsp27 might be due to MAPKAP kinase 2 activation occur-
ring independent of p38. Indeed, SB203580 does not completely
prevent stress-induced activation of MAPKAP-2 in LLC-PK1
cells (8). Alternatively, other protein kinases activated because
of DCVC treatment could potentially phosphorylate Hsp27 (8).
This may also explain the effect observed by inhibition of JNK
with SP600125, which resulted in decreased levels of phospho-
rylated p38 levels without affecting the stress-induced phos-
phorylation of Hsp27 (Fig. 4A). Under the latter circumstances,
the observed effects may also be a reflection of changes in the
dynamics of p38 activation versus Hsp27 phosphorylation
and/or dephosphorylation. The exact mechanism and the in-
volvement of different protein kinases and phosphatases re-
quires further investigation. Inhibition of p38 itself with
SB203580 did not affect p38 phosphorylation, which is most
likely due to the fact that the phosphorylation is mediated
by protein kinases (i.e. MMK3/6) that are not affected by
SB203580.
Inhibition of p38 with SB203580 accelerated the reorganiza-
tion of focal adhesions after DCVC treatment; this was associ-
ated with a more rapid cell detachment and onset of apoptosis.
In a similar fashion, stable overexpression of the Hsp27 phos-
phorylation mutant in LLC-PK1 cells also increased the sus-
ceptibility toward reorganization of focal adhesions caused by
DCVC as well as the induction of apoptosis. Together these
data fit with a model whereby cellular stress causes activation
of p38 thereby resulting (indirectly) in phosphorylation of
Hsp27, which in turn protects against the cellular insult. Al-
though our data support a role for Hsp27 phosphorylation in
protection against the reorganization of focal adhesions, over-
expression of mutant Hsp27 does not protect against a dephos-
phorylation of FAK. So far, we do not know the exact mecha-
nism by which Hsp27 affects focal adhesion organization.
Moreover, it cannot be excluded that Hsp27 phosphorylation
also modulates other routes that are essential for the onset of
apoptosis. Recent studies indicate that Hsp27 suppresses apo-
ptosis by maintenance of the F-actin network organization,
thereby preventing the mitochondrial release of cytochrome c
(52). F-actin disruption as a result of cell injury causes the
release of the Bcr homology 3-only pro-apoptotic Bcl-2 family
member Bmf that activates the mitochondrial pathway of apo-
ptosis (53); such a release is likely to be prevented if Hsp27
preserves F-actin organization. Alternatively, Hsp27 can bind
cytochrome c, which is an essential component for the forma-
tion of the apoptosome and activation of caspase-9 and ulti-
mately caspase-3 (54).
DCVC also caused the activation of JNK, which was associ-
ated with focal adhesions. Inhibition of JNK with SP600125
inhibited cell detachment and apoptosis. JNK localization at
focal adhesions is mediated through FAK (44). Overexpression
of GFP-FAT in LLC-PK1 cells prevents the localization of FAK
at focal adhesions, although there was an accelerated FAK
dephosphorylation after DCVC treatment. In GFP-FAT cells
little active JNK was associated with focal adhesions. Never-
theless, in GFP-FAT cells DCVC caused an equal c-Jun phos-
phorylation as well as a p38-mediated Hsp27 phosphorylation,
thus excluding a role for localization of active JNK is these
stress responses. Although inhibition of JNK inhibited cell
detachment, no clear protection against DCVC-induced focal
adhesion reorganization was observed. Also, inhibition of JNK
did not affect focal adhesion reorganization in either DCVC-
treated pkHsp27 or pkAA-Hsp27 cells (data not shown). In
contrast, SP600125 improved the maintenance of adherens
junctions as determined by immunofluorescence staining for
-catenin (data not shown). Paxillin, a downstream substrate
of the FAK/Src kinase complex at focal adhesions, is a down-
stream substrate of JNK, which seems related to the turnover
of focal adhesions. In LLC-PK1 cells, some paxillin is seen at
cell-cell junctions. Therefore, it is possible that JNK will phos-
phorylate paxillin at these cell-cell adhesion sites thereby in-
ducing a loss of cell-cell adhesions. Alternatively, other yet to
be identified substrates of JNK may affect these adhesions.
Although our data suggest a relationship between JNK-de-
pendent loss of cell adhesion and the onset of apoptosis, we
cannot exclude that DCVC-induced JNK activation results in
the phosphorylation of other cellular proteins that (in)directly
affect the onset of apoptosis.
Altogether, our 2D-DIGE approach resulted in the identifi-
cation of proteins that have been identified previously either as
direct targets of nephrotoxic cysteine conjugates or as proteins
being up-regulated after renal toxic stress. Hsp27 phosphoryl-
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ation plays a role in the suppression of the onset of cell death in
renal cells. Future studies are required to evaluate the role of
the other modified proteins in the control of nephrotoxicity.
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